Oral Administration of EP4-selective Agonist KAG-308 Suppresses Mouse Knee Osteoarthritis Development Through Reduction of Chondrocyte Hypertrophy and TNF Secretion

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-56861-6

Related search